Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07366905
PHASE2

Clinical Observation of Bupivacaine Liposome for Lower Extremity Nerve Block

Sponsor: Hainan Medical College

View on ClinicalTrials.gov

Summary

This prospective, sequential dose-finding clinical observational study aims to estimate the median effective concentration (EC50) and the 95% effective concentration (EC95) of liposomal bupivacaine for ultrasound-guided femoral nerve block. Sensory and motor block endpoints are evaluated separately at 30 minutes after block placement using a modified up-and-down (sequential allocation) design, with trial termination after eight reversal points.

Official title: Clinical Observation of Bupivacaine Liposome for Lower Extremity Femoral Nerve Block

Key Details

Gender

All

Age Range

18 Years - 85 Years

Study Type

INTERVENTIONAL

Enrollment

60

Start Date

2026-02

Completion Date

2026-03

Last Updated

2026-01-26

Healthy Volunteers

No

Interventions

DRUG

Liposomal bupivacaine, 266mg

Liposomal bupivacaine administered for ultrasound-guided femoral nerve block at varying concentrations using a modified up-and-down sequential dose-finding design.

Locations (1)

Department of Anesthesiology,the Second Affiliated Hospital of Hainan Medical University

Haikou, Hainan, China